title: Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis.
abstract: Immunosuppressive therapy is an established therapeutic option in patients suffering from multiple sclerosis (MS). In an open nonrandomized study we serially assessed cardiac function in 30 consecutive patients with MS before, during, and after mitoxantrone therapy. Mitoxantrone (12 mg/m(2)) was administered intravenously at 3-month intervals. Before each infusion, cardiac function was assessed by history taking, resting electrocardiogram, and echocardiography. Whereas no patient experienced clinical signs of heart failure, left ventricular pump function decreased continuously during mitoxantrone therapy and did not recover after cessation. The presented data suggest a dose-dependent and long-lasting toxic cardiac effect of low-dose mitoxantrone therapy in MS.
authors.affiliation: Berrenratherstr. 296, 50937 Köln, Germany.
authors.forename: Damian
authors.initials: D
authors.lastname: Franzen
authors.forename: Angelika
authors.initials: A
authors.lastname: Haus
authors.forename: Martin
authors.initials: M
authors.lastname: Hellmich
references.citation: Eur Neurol. 2005;54(1):28-33
references.pmid: 16088176
references.citation: Expert Opin Pharmacother. 2004 Apr;5(4):747-65
references.pmid: 15102561
references.citation: J Clin Pharmacol. 1995 Jun;35(6):627-32
references.pmid: 7665724
references.citation: J Neurol. 2008 Jan;255(1):140-1
references.pmid: 18004637
references.citation: J Cardiovasc Pharmacol. 2003 Nov;42(5):680-7
references.pmid: 14576518
references.citation: Lancet. 2002 Dec 21-28;360(9350):2018-25
references.pmid: 12504397
references.citation: Eur J Cancer. 2004 Mar;40(5):643-52
references.pmid: 15010064
references.citation: Mult Scler. 2003 Feb;9(1):59-62
references.pmid: 12617270
references.citation: Circulation. 1997 Mar 18;95(6):1686-744
references.pmid: 9118558
references.citation: Echocardiography. 2009 Apr;26(4):397-402
references.pmid: 19017314
references.citation: Ann Neurol. 2006 Jan;59(1):206-9
references.pmid: 16374818